. 2022 Mar 23;11(5):e210456. doi: 10.1530/EC-21-0456
This work is licensed under a Table 5.
DXA parameters, stratified by age range and by gender.
| Parameter | Patients up to 25 years (n = 12); group 1 | Patients from 26–50 years (n = 32); group 2 | Patients over 51 years (n = 21); group 3 | P value group 1 vs group 2 | P value group 1 vs group 3 | P value group 2 vs group 3 | Women (n = 38) | Men (n = 27) | P value women vs men |
|---|---|---|---|---|---|---|---|---|---|
| Age at DXA measurement (years) | 19.5 ± 4.3; range 13–25 | 36.9 ± 6.9;range 26–50 | 60.7 ± 7.4; range 51–79 | n.a. | n.a. | n.a. | 40.4 ± 16.6 | 42.7 ± 16.0 | Non-significant |
| Lumbar spine (L1–L4) BMD (g/cm2) | 0.968 ± 0.131 | 0.937 ± 0.132 | 0.779 ± 0.108 | Non-significant | P <0.01 | P <0.01 | 0.872 ± 0.140 | 0.930 ± 0.151 | Non-significant |
| Lumbar spine (L1–L4) T-score | −0.4 ± 1.5 | −1.3 ± 1.1 | −2.6 ± 0.9 | P < 0.05 | P <0.01 | P <0.01 | −1.5 ± 1.3 | −1.5 ± 1.4 | Non-significant |
| Lumbar spine (L1–L4) Z-score | −0.4 ± 1.5 | −1.0 ± 1.1 | −1.5 ± 0.9 | Non-significant | Non-significant | Non-significant | −1.0 ± 1.0 | −1.1 ± 1.4 | Non-significant |
| Femoral neck BMD (g/cm2) | 0.778 ± 0.117 | 0.721 ± 0.115 | 0.626 ± 0.079 | Non-significant | P <0.01 | P <0.01 | 0.669 ± 0.100 | 0.759 ± 0.125 | P <0.01 |
| Femoral neck T-score | −1.0 ± 0.9 | −1.5 ± 0.9 | −2.2 ± 0.6 | Non-significant | P <0.01 | P <0.01 | −1.8 ± 0.9 | −1.4 ± 0.9 | P <0.05 |
| Femoral neck Z-score | −1.0 ± 0.9 | −1.1 ± 0.9 | −1.1 ± 0.4 | Non-significant | Non-significant | Non-significant | −1.3 ± 0.7 | −0.8 ± 0.8 | Non-significant |
| Total femur BMD (g/cm2) | 0.849 ± 0.153 | 0.849 ± 0.190 | 0.785 ± 0.129 | Non-significant | Non-significant | Non-significant | 0.756 ± 0.107 | 0.946 ± 0.181 | P <0.01 |
| Total femur T-score | −1.0 ± 1.0 | −1.2 ± 1.0 | −1.6 ± 0.7 | Non-significant | P < 0.05 | Non-significant | −1.6 ± 0.9 | −0.8 ± 0.9 | P <0.01 |
| Total femur Z-score | −1.0 ± 1.0 | −0.9 ± 1.0 | −0.9 ± 0.7 | Non-significant | Non-significant | Non-significant | −1.1 ± 0.8 | −1.1 ± 0.8 | Non-significant |
| Normal BMD value (%) | 5/12 (41.7) | 10/32 (31.2) | 0/21 (0) | Non-significant | P < 0.01 | P < 0.01 | 7/38 (18.4) | 7/27 (25.9) | Non-significant |
| Osteopenia (%) | 6/12 (50.0) | 14/32 (43.8) | 9/21 (42.9) | Non-significant | Non-significant | Non-significant | 16/38 (42.1) | 14/27 (51.9) | Non-significant |
| Osteoporosis (%) | 1/12 (8.3) | 8/32 (25.0) | 12/21 (57.1) | Non-significant | P <0.01 | P < 0.05 | 15/38 (39.5) | 6/27 (22.2) | Non-significant |
n.a., not applicable.
Parameters presenting a significant difference between different groups of patients are highlighted in bold, with P < 0.05 indicating a statistical significance of 95%, and P < 0.09 indicating a statistical significance of 99%.